Deepull
- Focus
- Sepsis diagnosis
- Location
- Spain
- Investment date
- Sept. 2022
Deepull is a biotechnology company developing an early diagnosis of sepsis and therapeutic recommendations. The company’s diagnostic system will detect pathogens and antibiotic resistances within a few hours, without a prior cultivation stage, enabling patients to get treated in the early stages of the disease.